SPS
RMD icon

Susquehanna Portfolio Strategies’s ResMed RMD Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-107,194
Closed -$26.2M – 264
2024
Q3 		$26.2M Sell
107,194
-4,886
-4% -$1.09M 1.79% 8
2024
Q2 		$21.5M Sell
112,080
-2,200
-2% -$446K 0.88% 25
2024
Q1 		$22.6M Sell
114,280
-12,943
-10% -$2.37M 0.53% 45
2023
Q4 		$21.9M Buy
+127,223
New +$19.5M 0.39% 66

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Susquehanna Portfolio Strategies's RMD Position: Q4 2024 in Review

Susquehanna Portfolio Strategies sold out of ResMed (RMD) in Q4 2024, closing a stake of 107,194 shares — an estimated $26.2M sold.

Susquehanna Portfolio Strategies first reported a position in RMD in Q4 2023 and held it in 4 quarters. The position peaked at $26.2M in Q3 2024. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Susquehanna Portfolio Strategies reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 107,194 ResMed shares in Q4 2024, an estimated $26.2M.
  • Susquehanna Portfolio Strategies first reported a position in ResMed in Q4 2023 and held it in 4 quarters.
  • Susquehanna Portfolio Strategies's ResMed position peaked at $26.2M in Q3 2024.
  • 872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.